LARGE1 (AA 35-142) antibody (PE)
Quick Overview for LARGE1 (AA 35-142) antibody (PE) (ABIN2749158)
Target
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 35-142
-
Purpose
- Anti-LARGE1 PE
-
Specificity
- The mouse monoclonal antibody LARGE-02 recognizes human LARGE1, a glycosyltransferase expressed mainly in the Golgi apparatus. Crossreactivity with LARGE2 was not determined.
-
Cross-Reactivity (Details)
- Human
-
Purification
- Purified antibody is conjugated with R-phycoerythrin (PE) under optimum conditions. Unconjugated antibody and free fluorochrome are removed by size-exclusion chromatography.
-
Immunogen
- Recombinant fragment of human LARGE1 (amino acids 35-142)
-
Isotype
- IgG2b
-
-
-
-
Application Notes
- Flow cytometry: Recommended dilution: 1-5 μg/mL. Intracellular staining.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.1 mg/mL
-
Buffer
- Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.
-
-
- LARGE1
-
Background
- LARGE xylosyl- and glucuronyltransferase 1,LARGE1 serves as a glycosyltransferase which participates in glycosylation of the muscle membrane protein alpha-dystroglycan. Mutations of LARGE1 lead to hypoglycosylation of alpha-dystroglycan and cause congenital muscular dystrophy (MDC1D) associated with severe mental retardation. Altered alpha-dystroglycan glycosylation may also play a role in cancer, as hypoglycosylation of the protein and loss of laminin binding have been demonstrated in invasive carcinoma cells.,Xysosyl- and glucosyl transferase 1
-
Gene ID
- 9215
-
UniProt
- O95461
Target
-